Estradiol-induced protection against ischemia-induced heart mitochondrial damage and caspase activation is mediated by protein kinase G

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1797, Issue 6-7, 2010, Pages 1012-1017

  Morkuniene, Ramune ^a   Arandarcikaite, Odeta ^a   Ivanoviene, Laima ^a   Borutaite, Vilmante ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Cytochrome c; Estrogens; Ischemia; Mitochondria; Protein kinase G

Indexed keywords

CASPASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYTOCHROME C; ESTRADIOL; GUANYLATE CYCLASE INHIBITOR; KT 5823; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; ISOLATED HEART; METABOLIC INHIBITION; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CALCIUM; CARBAZOLES; CASPASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; CYTOCHROMES C; ENZYME ACTIVATION; ESTRADIOL; FEMALE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MODELS, CARDIOVASCULAR; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77953810542     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2010.03.027     Document Type: Article

References (42)

1. Hale S.L., Birnbaum Y., Cloner R.A. Beta-estradiol, but not alfa-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am. Heart J. 1996, 132:258-262.
2. Zhai P., Eurell T.E., Cotthaus R., Jeffery E.H., Bahr J.M., Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H2766-H2775.
3. Booth E.A., Marchesi M., Kilbourne E.J., Lucchesi B.R. 17Beta-estradiol as a receptor-mediated cardioprotective agent. J. Pharmacol. Exp. Ther. 2003, 307:395-401.
4. Babiker F.A., De Windth L.J., Eickels M., Grohe Ch., Meyer R., Doevendans P.A. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc. Res. 2002, 53:709-719.
5. Murphy E., Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 2007, 75:478-486.
6. Simoncini T., Hafezi-Moghadam A., Brazil D.P., Ley K., Chin W.W., Liao J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000, 407:538-541.
7. Fu X.D., Simoncini T. Extra-nuclear signaling of estrogen receptors. IUBMB Life 2008, 60:502-510.
8. Cimarosti H., Zamin L.L., Frozza R., Nassif M., Horn A.P., Tavares A., Netto C.A., Salbego C. Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3beta. Neurochem. Res. 2005, 30:191-199.
9. Vasconsuelo A., Milanesi L., Boland R. 17Beta-estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Endocrinol. 2008, 196:385-397.
10. Bae S., Zhang L. Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J. Pharmacol. Exp. Ther. 2005, 315:1125-1135.
11. Patten R.D., Pourati I., Aronovitz M.J., Baur J., Celestin F., Chen X., Michael A., Haq S., Nuedling S., Grohe C., Force T., Mendelsohn M.E.R.H. Karas. 17Beta-estradiol reduces apoptosis in vivo and in vitro via activation of phospho-inositide-3kinase/Akt signaling. Circ. Res. 2004, 95:692-699.
12. Hausenloy D.J., Duchen M.R., Yellon D.M. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc. Res. 2003, 60:617-625.
13. Griffiths E.J., Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 1995, 307:93-98.
14. Scarlett J.L., Murphy M.P. Release of apoptogenic proteins from the mitochondrial intermembrane space during the mitochondrial permeability transition. FEBS Lett. 1997, 418:282-286.
15. Di Lisa F., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc. Res. 2006, 70:191-199.
16. Argaud L., Gateau-Roesch O., Augeul L., Couture-Lepetit E., Loufouat J., Gomez L., Robert D., Ovize M. Increased mitochondrial calcium coexists with decreased reperfusion injury in postconditioned (but not preconditioned) hearts. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H386-H391.
17. Morkuniene R., Jekabsone A., Borutaite V. Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria. FEBS Lett. 2002, 521:53-56.
18. Morkuniene R., Arandarcikaite O., Borutaite V. Estradiol prevents release of cytochrome c from mitochondria and inhibits ischemia-induced apoptosis in perfused heart. Exp. Gerontol. 2006, 41:704-708.
19. Gornal A.G., Bardavill G.J., David M. Determination of serum proteins by means of the biuret reaction. J. Biol. Chem. 1949, 177:751-766.
20. Rieske J.S. Methods Enzymol. 1967, 10:488-493.
21. Borutaite V., Jekabsone A., Morkuniene R., Brown G.C. Inhibition of mitochondrial permeability transition prevents mitochondrial dysfunction, cytochrome c release and apoptosis induced by heart ischemia. J. Mol. Cell. Cardiol. 2003, 35:357-366.
22. Crompton M., Ellinger H., Costi A. Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 1988, 255:357-360.
23. Halestrap A.P., Davidson A.M. Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem. J. 1990, 268:153-160.
24. Juhaszova M., Zorov D.B., Kim S.H., Pepe S., Fu Q., Fishbein K.W., Ziman B.D., Wang S., Ytrehus K., Antos C.L., Olson E.N., Sollott S.J. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest. 2004, 113:1535-1549.
25. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008, 117:2761-2768.
26. Borutaite V., Morkuniene R., Budriunaite A., Krasauskaite D., Ryselis S., Toleikis A., Brown G.C. Kinetic analysis of changes in activity of heart mitochondrial oxidative phosphorylation system induced by ischemia. J. Mol. Cell. Cardiol. 1996, 28:2195-2201.
27. Rasola A., Sciacovelli M., Chiara F., Pantic B., Brusilow W.S., Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:726-731.
28. Xi J., Wang H., Mueller R.A., Norfleet E.A., Xu Z. Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur. J. Pharmacol. 2009, 604:111-116.
29. Nagoshi T., Matsui T., Aoyama T., Leri A., Anversa P., Li L., Ogawa W., del Monte F., Gwathmey J.K., Grazette L., Hemmings B.A., Kass D.A., Champion H.C., Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury, J, Clin. Invest 2005, 115:2128-2138.
30. Matsui T., Tao J., Del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104:330-335.
31. Majewski N., Nogueira V., Bhaskar P., Coy P.E., Skeen J.E., Gottlob K., Chandel N.S., Thompson C.B., Robey R.B., Hay N. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 2004, 16:819-830.
32. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605.
33. Lochner A., Marais E., Genade S., Moolman J.A. Nitric oxide: a trigger for classic preconditioning?. Am. J. Physiol. 2000, 279:H2752-H2765.
34. ATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc. Res. 2007, 75:168-177.
35. Burley D.S., Ferdinandy P., Baxter G.F. Cyclic GMP and protein kinase-G in myocardial ischemia-reperfusion: opportunities and obstacles for survival signaling. Br. J. Pharmacol. 2007, 152:855-869.
36. Takuma K., Phuagphong P., Lee E., Mori K., Baba A., Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 2001, 276:48093-48099.
37. 2 inhibit the mitochondrial permeability transition. J. Biol. Chem. 2006, 281:20801-20808.
38. Borutaite V., Morkuniene R., Arandarcikaite O., Jekabsone A., Barauskaite J., Brown G.C. Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release. J. Biomed. Sci. 2009, 11:16-70.
39. Kim J.S., Ohshima S., Pediaditakis P., Lemasters J.J. Nitric oxide: a signalling molecule against mitochondrial permeability transition- and pH-dependent cell death after reperfusion. Free Radic. Biol. Med. 2004, 37:1943-1950.
40. Jennings B. Calcium ions in ischemia. Calcium antagonists and cardiovascular disease 1984, 85-95. Raven Press, New York. L.H. Opie (Ed.).
41. Gunter T.E., Gunter K.K., Sheu Sh.-S.h., Gavin C.E. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 1994, 267:C313-C339.
42. Sun J., Picht E., Ginsburg K.S., Bers D.M., Steenbergen C., Murphy E. Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ. Res. 2006, 98:403-411.